Consolidated Statements Of Operations - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Revenue
Operating Expenses:
Sales and Marketing	232,084	60,487
General and Administrative	369,538	188,789
Research and Development	545,639	901,857
Impairment Expense		6,285,214
Total Operating Expenses	1,147,261	7,436,347
Loss from Operations	(1,147,261)	(7,436,347)
Other Expense (Income)
Interest Expense, Net	1,316,407	318,038
Bank and Financing Fees	19,799	23,147
Miscellaneous Income	(178,394)	(10,000)
Total Other Expense	1,157,812	331,185
Loss Before Income Tax	(2,305,073)	(7,767,532)
Income Tax
Current
Deferred
Loss from Continuing Operations, Net	(2,305,073)	(7,767,532)
Discontinued Operations:
Income from Discontinued Operations		178,300
Income Tax		37,367
Income from Discontinued Operations, Net		140,933
Net Loss	(2,305,073)	(7,626,599)
Less: Preferred Stock Dividends	10,000	10,000
Net Loss Available to Common Stockholders	$ (2,315,073)	$ (7,636,599)
Net Loss From Continuing Operations per Common Share:
Basic	$ (0.03)	$ (0.11)
Diluted	(0.03)	(0.11)
Net Earnings From Discontinued Operations per Common Share:
Basic
Diluted
Net Loss per Common Share:
Basic	(0.03)	(0.10)
Diluted	$ (0.03)	$ (0.10)
Weighted Average Number of Common Shares Outstanding - Basic	71,297,272	73,771,722
Weighted Average Number of Common Shares Outstanding - Diluted	71,297,272	73,771,722